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Abstract
Background & Aims—Fecal incontinence (FI) affects 15% of people age 70 years and older, 
but only 10%–30% discuss FI with their physicians. We aimed to identify barriers that prevent 
people from consulting with their physicians, and physicians from screening for FI.
Methods—We performed structured interviews of 124 individuals with FI (mean 56 years old, 
87.9% women) recruited from 6 medical offices at the University of North Carolina Hospitals 
from June 2012 through March 2013. The subjects completed the Fecal Incontinence Severity 
Index and Fecal Incontinence Quality of Life Scale questionnaires. Interview questions aimed to 
determine which patients had consulted physicians for FI. Eleven of the 56 physicians with 
patients included in the study responded to the survey.
Results—Eighty-eight of the 124 participants consulted with their physicians about FI 
(consulters). These individuals had a higher incidence of depression than the 36 subjects who did 
not consult with their physicians about FI (non-consulters; P=.04), but similar Fecal Incontinence 
Severity Index scores. A smaller proportion of non-consulters were aware of available treatments 
than consulters (P<.01). Fifty-six percent of non-consulters said their FI was not serious enough to 
consult a physician. There was no difference between consulters and non-consulters in 
embarrassment in talking about FI. Among consulters, 88% initiated the conversation about FI 
with their physician. Seven of the 11 responding physicians screened for FI, and only screened 
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high-risk patients. The 4 physicians who did not screen for FI were unaware of its prevalence, 
viewed FI as a low priority, or stated that patients were responsible for reporting their own 
symptoms.
Conclusions—Based on surveys of physicians and patients, many patients have insufficient 
knowledge about the availability and effectiveness of treatments for FI. Some people with FI do 
not discuss it with their physician because their symptoms are mild, and most prefer physicians to 
ask them directly about FI. Educating patients and physicians about the prevalence of FI and 
management strategies may improve rates of consultation rates.
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Introduction
Fecal incontinence (FI) is the inability to control bowel movements which may result in the 
accidental loss of liquid stool, solid stool, or mucus. The prevalence of FI is unrelated to race 
or ethnicity2,3 and is estimated to be 7-12% in non-institutionalized U.S. adults1, 2. It is more 
common among women than men (9.4% vs. 7.3%)3. FI affects over 15% of people aged 70 
and older, and the presence of FI increases the likelihood of elderly adults being admitted 
into nursing homes2. The impact on quality of life (QOL) depends partly on the frequency 
and severity of FI which varies from daily loss of all stools to infrequent staining of 
underwear4. An estimated 2.7% of adults report leakage of solid or liquid stool at least 
weekly2. The impact of FI may include embarrassment, social isolation, job loss, and 
depression5.
Although effective treatments are available for FI, surveys suggest only 10%4 to 30%6 of 
patients discuss treatment options with their physician. A lack of systematic screening for FI 
by clinicians compounds this problem7. The study goals were (1) to identify reasons patients 
fail to consult their physician about FI and (2) identify reasons physicians fail to screen for 
FI. We tested the following hypotheses:
1. Patients with FI may fail to consult physicians because:
a. Non-consulters are less aware of treatment options for FI than consulters
b. Non-consulters are more likely to have higher scores on the Charlson Index 
of Disease Comorbidity8.
c. Non-consulters have a lower expectation that FI can be improved
d. Non-consulters are more embarrassed than consulters about discussing FI
2. Physicians may fail to screen for FI because:
a. Non-screeners are more likely than screeners to believe FI is rare
b. Non-screeners believe FI has less impact on the patient's QOL
c. Non-screeners rate FI as less important to screen for than elevated 
triglycerides, diabetes, excessive use of alcohol, or urinary incontinence.
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3. Through open-ended questions, we also sought to identify novel differences 
between patient consulters and non-consulters, and between physician screeners 
and non-screeners that may explain possible barriers to obtaining treatment for FI.
Methods
Based on an a priori power analysis, the targeted enrollment was 128 patients with FI, which 
is based on t-tests with an alpha of 0.05, power of 0.80, and an effect-size of 0.5 standard 
deviations. Patients were recruited from six waiting rooms of the University of North 
Carolina Hospitals over 20 weeks. These included primary care clinics (family medicine and 
internal medicine) and specialty clinics (gastroenterology, geriatric medicine, 
urogynecology, and rheumatology). To minimize embarrassment, patients completed an 
anonymous checklist by identifying general gastrointestinal symptom(s) they experienced in 
the past month (Table 1), and those who answered positively to FI and were at least 18 years 
of age were invited to participate.
After giving written consent, patients and/or caregivers completed the modified Fecal 
Incontinence Severity Index (FISI)9 and Fecal Incontinence Quality of Life (FIQOL)10 
questionnaire. A structured interview was also completed in the clinic or by telephone. 
Family caregivers were permitted to assist in answering questions. Medical records were 
reviewed to collect data to permit calculation of the Charlson Index of Disease 
Comorbidity8. Upon completion of the study, patients received a check for $25.
Fecal Incontinence Severity Index
The FISI consists of 4 questions about the frequency of different types of bowel leakage: 
solid, liquid, mucus, and gas. The answer choices for the frequency of leakage were one to 
three times per month (coded 1), once per week (2), two or more times a week (3), once per 
day (4), and two or more times per day (5). Scoring of the FISI was previously explained9. 
Because we believe patients are better able to judge subjective qualities such as 
embarrassment and disruption of activities, patients' weighted scores rather than physician 
weighted scores were summed to obtain a total FISI score.
The FISI was modified by adding questions related to volume of solid, liquid, and mucus 
leakage. The possible responses were coded as: “Never” (0), “Stain only on underwear or 
pad” (1), “Small amount – 1-2 teaspoons” (2), “Moderate amount – 3-5 teaspoons” (3), 
“Large amount – ½ cup to 1 cup” (4), and “Full bowel movement” 5). Questions related to 
sound and odor for gas leakage were added, and the answer choices were coded as: “None” 
(0), “Not noticeable” (1), “Somewhat noticeable” (2), and “Definitely noticeable” (3). 
Responses of “Refused” and “Don't know” were treated as missing values.
Fecal Incontinence Quality of Life
The FIQOL questionnaire consists of a total of 29 questions to assess the patient's quality of 
life. There are four categories: lifestyle (10 questions), coping/behavior (9 questions), 
depression/self-perception (7 questions), and embarrassment (3 questions). The responses 
are coded as: “Most of the time” (4), “Some of the time” (3), “A little of the time” (2), and 
“None of the time” (1). Higher numerical responses indicate a poorer QOL. The first 
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question, which evaluates general health, was reverse coded for consistency. A mean score 
was calculated for each category. The response “Does not apply” was coded as a missing 
value. The FIQOL total score was calculated by adding the responses for all four categories.
Patient Interviews
Patients and/or caregivers were interviewed to assess beliefs and experiences regarding FI. 
The interview included questions on whether patients had discussed FI with their physician. 
A follow-up question inquired whether the patient or physician initiated the discussion about 
FI. Non-consulters chose from a list of pre-hypothesized reasons for not disclosing their FI 
to a physician (Table 4). All patients rated how much embarrassment was caused by 
consulting with their physicians about FI on a scale from 0 to 10, with 10 indicating extreme 
embarrassment. Patients also answered questions to assess their awareness and knowledge of 
FI treatment options and their expectation for treatment success. Additional qualitative 
questions elicited how patients coped with FI and their suggestions for improving open-
communication with their physicians about FI.
Physician Interviews
The physicians treating these patients were e-mailed questions about their screening 
practices. They were also asked questions eliciting demographic information, their 
knowledge of FI prevalence in their patient population, whether FI affects quality of life, 
whether they actively screened for FI and what were their criteria (if any) for screening, and 
frequency for screening. Open-ended questions inquired about preferred treatment options 
and potential barriers for their patients to obtain treatment. If physicians were non-screeners, 
they provided reasons for not screening and compared the importance of screening for FI to 
screening for other health conditions.
Ethics Review
The study was approved by the Institutional Review Board of the University of North 
Carolina at Chapel Hill on May 21, 2012.
Statistical Analysis
The consulters were compared to non-consulters on a variety of characteristics using t-tests 
for independent samples. An alpha level of 0.05 was used for each 2-tailed test without 
correction for multiple comparisons. Descriptive analyses were employed to characterize the 
non-consulters and to explore reasons for not consulting.
Results
A total of 1373 patients were screened using the anonymous checklist, of which 195 
(14.2%) reported experiencing FI within the past month. Of this subgroup, 129 (66%) 
consented to participate, but only 124 completed all parts of the study. A comparison of 
consented patients to patients who withheld their consent showed that study participants 
were representative (Table 1): The number of gastrointestinal symptoms reported by 
individuals who consented to participate (4.4±1.9; mean±SD) was not significantly different 
compared to those who withheld their consent (4.0±2.2; p=0.2).
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Anonymous gastrointestinal symptom checklist
Table 1 compares the total number of gastrointestinal symptoms on the anonymous checklist 
reported by patients with and without FI. The average number of gastrointestinal symptoms 
per person without FI was 1.4±1.7 compared to 4.3±2.0 for people reporting FI (p=0.0001). 
Each gastrointestinal symptom on the checklist was endorsed more frequently by patients 
with FI compared to patients without FI (p=0.0001). Consulters were more likely than non-
consulters to report diarrhea (68.2% vs. 33.3%; p=0.002).
Demographic characteristics
Demographic characteristics of the 124 participants and their clinics of origin are 
summarized in Table 2. This table also compares consulters to non-consulters on the 
Charlson Index of Comorbidity, FISI, and FIQOL. Contrary to our hypothesis, there were no 
significant differences in the Charlson Index of Comorbidity between consulters and non-
consulters (2.2±2.5 for consulters and 2.4±2.8 for non-consulters, p=0.6). Also, no 
significant differences were found on the FISI and FIQOL except on the depression subscale 
of the FIQOL (i.e., greater impact on depression in consulters; p=0.04).
Knowledge of Treatments and beliefs about their effectiveness
As predicted, non-consulters were less likely to know of any available treatments for FI 
(p=0.001). Participants who responded “Don't know” were grouped with those whose 
responses were “No”: 29 of 36 non-consulters (81%) were unaware of available treatment 
compared to 41 of 88 consulters (47%, p=0.002). Consulters were aware of the following 
treatments: over the counter medication (59%), biofeedback therapy (27%), surgery (23%), 
exercise (35%), and diet modification (36%); while non-consulters were aware of 
biofeedback (8%), over the counter medication (14%), and surgical treatments (3%). 
Approximately, half of the participants (48%) knew about more than one available treatment.
Five out of 7 non-consulters who knew of available treatments believed these treatments 
were effective: 2 believed available treatments could completely cure FI, and 3 believed they 
are very effective. Only 2 remaining non-consulters believed treatments to be not effective. 
Among the 47 consulters, 3 viewed treatments as able to produce a complete cure, 19 
viewed them as very effective, 22 as somewhat effective, and 3 as not effective. There were 
no significant differences between consulters' and non-consulters' views on effectiveness of 
available treatment for FI (p=0.45).
Self-help strategies
Self-help strategies used to minimize the impact of FI were grouped into five categories 
(Table 3). Only 17% of consulters and 22% non-consulters did not use any self-help 
strategies, p=0.51. Consulters were more likely than non-consulters to take over-the-counter 
medication (p<0.01) and to limit food intake before leaving home (p=0.05). Consulters used 
more self-help strategies (1.7±1.2) compared to non-consulters (1.2±0.9), p=0.01.
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Embarrassment and other reasons for not discussing FI with physicians
There was no significant difference between non-consulters and consulters when participants 
rated how much embarrassment was caused by discussing FI. On a ten point scale with zero 
being no embarrassment and 10 being extreme embarrassment, non-consulters averaged 
3.6±3.7 compared to 3.4±3.6 for consulters (p=0.87). The embarrassment subscale of the 
FIQOL questionnaire similarly showed no difference: 2.7±0.9 for non-consulters compared 
to 2.5±0.9 for consulters (Table 2, p=0.40).
In addition to embarrassment, other reasons that non-consulters reported for not discussing 
FI with their physicians are listed in Table 4. Non-consulters were more likely to view FI as 
a natural process of aging in comparison to consulters (p=0.0001). In line with our 
predictions, 36% of non-consulters mentioned embarrassment as one reason for not 
consulting.
Non-consulters who reported their FI as “serious” vs. “not serious”
The 56% of non-consulters who did not think their symptoms were serious enough to seek 
medical care was unexpected. We explored this with a post-hoc analysis comparing the 
severity of FI between non-consulters who viewed their FI as “not serious” to non-consulters 
who viewed their FI as “serious” (Table 5). The “not serious” non-consulters had 
significantly fewer bowel accidents consisting of liquid stool (p=0.04) and mucus (p=0.02), 
and the overall FISI scores tended to be lower (21.9±9.6) compared to the “serious” non-
consulters (26.1±13.3; p=0.07). “Not-serious” non-consulters were also more likely to view 
FI as a natural progression of aging (p=0.0001) and to use an over-the-counter medication to 
manage FI (p=0.04) compared to “serious” non-consulters.
How to improve consultation rates
Participants provided suggestions for ways to facilitate consultations by future patients with 
FI (Table 6). Both consulters (57%) and non-consulters (72%) thought physicians should 
directly ask their patients about FI. Also, 49% of all participants recommended that medical 
personnel use questionnaires or insert questions about FI in the patient history collected 
before physician visits. Study participants indicated that physicians rarely screen for FI. 
Only 12% of the participants were asked by their physicians about FI in specialty clinics 
while 13% were screened by their physicians in primary care clinics. Among the consulters, 
88% said the discussion(s) about FI were initiated by themselves.
Participants stated physicians should be aware of other issues that may lead to FI. In both 
consulters and non-consulters, 52% believed their FI was due to another medical issue, 27% 
due to surgical complications, and 23% due to medication side-effects. Participants 
mentioned other factors that may have caused their FI: 25% believed they had weak pelvic 
floor muscles, 22% stated they have poor diet habits, 21% viewed FI as a natural part of 
aging, 19% of female participants experienced difficult vaginal deliveries, and 17% were 
unsure of what caused their FI.
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Physician characteristics and responses
Fifty-six physicians were emailed the survey. Eight geriatricians, one rheumatologist, one 
general internist, and one gastroenterologist responded. Among these 11, two geriatricians, 
the rheumatologist and the general internist were non-screeners. There was no significant 
gender difference between the screeners and non-screeners (p=0.08). Of the four non-
screeners, three reported that FI was rare (<5% prevalence) in the general patient population. 
Though both screeners and non-screeners viewed FI as having a significant impact on the 
patient's QOL, non-screeners considered FI as less important to screen for compared to other 
health issues such as elevated triglycerides, diabetes, excessive use of alcohol, and urinary 
incontinence. Half of the non-screeners acknowledged time restriction as the major barrier to 
screen. All non-screeners reported the patient or caregiver is responsible for addressing FI 
issues if the symptoms become severe enough to seek medical care. Among the seven 
physicians who screened for FI, only one believed FI is rare while the remaining six believed 
that at least 10% of the general population experiences FI. All stated they screen only 
selected patients with other conditions and/or symptoms considered to be risk factors for FI. 
All screeners prescribed different treatments based on the etiology and severity of the 
patient's FI. When asked about barriers for screening or addressing FI, 50% of screeners 
stated that accessibility to subspecialty care is limited and that medical costs may outweigh 
the benefits of receiving expensive treatments such as biofeedback or surgery.
Discussion
The purpose of this study was to identify reasons why fewer than 30% of people with FI 
discuss this problem with their physician. We were able to confirm several a priori 
hypotheses. For example, non-consulters are less aware of treatment options available for FI. 
Due to this knowledge deficit, non-consulters have lower expectations for medical treatment 
methods to improve FI. This knowledge deficit issue could be addressed by public 
awareness programs and patient educational brochures in clinic waiting and examination 
rooms.
Our a priori hypothesis that embarrassment is a major deterrent to seeking medical care for 
non-consulters was not confirmed. There was no significant difference in the self-reported 
embarrassment ratings between consulters and non-consulters. Non-consulters were more 
likely to view their FI as a natural part of aging compared to consulters (p=0.0001). The 
reasons they gave for not consulting (Table 4) and what they believe caused their FI (i.e., FI 
caused by another medical illness, post-surgical complication, and medication side-effects) 
provide possible explanations for the failure to find a strong association between non-
consulting and embarrassment.
An unexpected finding was that 56% of non-consulters did not think their FI was serious 
enough to consult a physician. A post hoc comparison between consulters and the subgroup 
of non-consulters who viewed their FI as “not serious enough to consult” suggests these 
non-consulters actually have less severe FI: their total FISI scores were lower than those of 
the consulters (p=0.04), and they reported significantly fewer bowel accidents consisting of 
liquid (p<0.02) and mucus (p<0.002) FI. These data suggest that a subgroup of people with 
FI do not consult physicians because their FI is less severe and they view it as a normal part 
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of aging and/or not a medical problem; these individuals are distinct from other non-
consulters who find it embarrassing to discuss FI with their physician, and are less 
knowledgeable about treatments for FI. The 56% of “not serious” non-consulters may not be 
targets for intervention; however, other individuals whose failure to consult physicians may 
be related to a lack of awareness of treatment options, may benefit from screening and 
treatment programs.
Most people with FI employ self-management strategies such as pad use and non-
prescription medications to control diarrhea and constipation whether they are consulters 
(87%) or non-consulters (78%). Consulters use significantly more of these strategies than 
non-consulters (Table 3), probably because more than half of non-consulters have milder 
symptoms of FI which they do not regard as serious enough to consult physicians for. The 
self-help strategies used more often by consulters than non-consulters were medications to 
control diarrhea or constipation, and restricting food intake to minimize FI. Food restriction 
is a maladaptive method of managing FI that is employed by 32.4% of people with FI.
We predicted non-consulters would have higher Charlson Comorbidity Index scores than 
consulters, because patients with multiple chronic illnesses may be more concerned about 
other pressing health issues. Thus, they would be less likely to consult for FI and view FI as 
a normal sequel to other disease processes. However, the Charlson Index was not 
significantly higher in non-consulters compared to consulters.
The purpose of the physician surveys was to learn what influences their decision to screen 
for FI. Seven of the 11 physicians reported that they screen for FI, but all indicated they 
screen only high-risk patients. They indicated that limited access to subspecialists who treat 
FI and the high costs of treatments such as biofeedback, surgery, or surgical implants, 
discourages them from screening. As predicted, non-screeners were less knowledgeable 
about FI: 50% thought FI is less prevalent than epidemiological studies suggest and they 
think it is the patient's responsibility to bring up FI during consultation. Also non-screeners 
believed FI is less important to screen for compared to other health conditions. Though 7 of 
the 11 physicians indicated they were regular screeners for FI, the responses of the patients 
in this study do not support this: 88% of consulters stated they initiated the conversation 
about FI with their physician.
This study has several limitations. The participation rate was 63% for people who reported 
having FI on the anonymous gastrointestinal symptom checklist; this is acceptable but 
relatively low. However, the non-participants with FI reported similar rates of 
gastrointestinal symptoms compared to participants without FI, which suggests that the 
sample is probably representative of all people with FI. A second limitation is that the 
physician sample size was too small and the proportion of physicians who provided data was 
low at 19.6%. Clearly inferences about physician screening behavior will need to be 
confirmed. A third concern is that the proportion of people with FI who reported consulting 
physicians was higher than expected: 71% in this study compared to 30% or less in previous 
reports6, which raises a concern that the sample could be biased by self-selection (i.e., non-
consulters may be less willing to participate in the study). A possible explanation may be 
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that the majority of recruited patients were from specialty clinics. Further studies, especially 
in primary care clinics, are needed to confirm our findings.
Implications for clinical practice
A key finding of our study is that non-consulters with FI are not a homogenous group; there 
is a subset who do not consult because they are unaware that effective treatments exist, and 
there is a different subset of patients who do not consult because they do not believe their 
symptoms are severe enough to require medical management. Post hoc analysis confirmed 
that people with FI who do not believe their symptoms are serious enough to require 
treatment actually have fewer liquid and mucus bowel accidents than people who list other 
reasons for not consulting. This supports the concept that costly and aggressive treatments 
for FI should be reserved for people with frequent bowel accidents while those with 
infrequent and milder symptoms may be satisfied with conservative self-management 
practices. Further research is needed to define severity thresholds that can guide practice.
Another key finding of this study is that most people with FI (61%) prefer that their 
physicians screen them for the presence of FI, although this is not current practice; instead 
many physicians believe it is the patient's responsibility to bring this up. People with FI also 
expressed a strong preference that screening for FI be done by questionnaire rather than 
direct questioning, perhaps because they find it embarrassing to discuss this symptom.
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Sample Size 88 36
Mean Age (years) 55.7 57.1
Mean Onset Age (years) 47.7 52.5
Gender (%) 89.8% Female 79/88 83.3% Female 30/36
Race (%)
67.0% Caucasian (59/88), 20.5% African 
American (18/88), 5.7% Native American (5/88), 
6.8% Hispanic (6/88)
69.4% Caucasian (25/36), 25% African 
American (9/36), 5.6% Native American (2/36), 
0.0% Hispanic (0/36)
Clinic of Origin (%)
37.5% GI Clinic (33/88), 30.7% Urogynecology 
(27/88), 17.0% Geriatrics (15/88), 10.2% Internal 
Medicine (9/88), 3.4% Family Medicine (3/88), 
1.1% Rheumatology (1/88)
27.8% GI Clinic (10/36), 36.1% Urogynecology 
(13/36), 27.8% Geriatrics (10/36), 8.3% Internal 
Medicine (3/36), 0.0% Family Medicine (0/36), 
0.0% Rheumatology (0/36)
Who provided information? (%)
92.0% Patient (81/88), 5.7% Caregiver (5/88), 
2.3% Both (2/88)
88.9% Patient (32/36), 8.3% Caregiver (3/36), 
2.8% Both(1/36)
Charlson Index (mean ± SD) 2.2±2.5 2.4±2.8
Patient FISI (mean ± SD) 27.3±12.4 23.8±11.4
FIQOL Lifestyle (mean ± SD) 2.7±1.0 2.9±0.9
FIQOL Coping (mean ± SD) 2.1±0.8 2.3±0.9
FIQOL Depression (mean ± SD) 2.9±0.8 3.3±0.9
FIQOL Embarrassment (mean ± SD) 2.5±0.9 2.7±0.9
FIQOL Total Score (mean ± SD) 10.4±2.9 11.3±3.2
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Table 3
Self-help methods for managing FI.
Consulters (%) Non-Consulters (%) Significance
Use pads 53.4 47/88 38.9 14/36 0.14
Use medication 44.3 39/88 8.3 3/36 0.00
Limit food intake 37.5 33/88 19.4 7/36 0.05
Routine restroom breaks 26.1 23/88 30.6 11/36 0.62
Avoid leaving home 15.9 14/88 25.0 9/36 0.24













Kunduru et al. Page 14
Table 4
Reasons non-consulters gave for not consulting their physician about FI.
Response Non-consulters
Do not think it is serious enough* 55.6 20/36
Think it is normal with aging* 41.7 15/36
Personal embarrassment* 36.1 13/36
Do not think it is a real medical problem* 36.1 13/36
Uncomfortable with specific physician (gender) * 20.0 7/36
Do not think treatment exists 13.9 5/36
Patients believe physicians are unable to help with FI symptoms 13.9 5/36
Not enough time to discuss because of other health problems 11.1 4/36
Uncomfortable with any physician* 5.7 2/36
Think physician would be embarrassed* 2.9 1/36
Want a natural solution 2.9 1/36
Expected medical side effect 2.9 1/36
*
Options given to non-consulters as reasons for not disclosing FI to their physicians.
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Table 6
Patient suggestions for improving FI consultation.
Consulter Non-Consulter Total
Doctors need to speak directly to patients 56.8 50/88 72.2 26/36 61.3 76/124
Patients prefer to use questionnaires or answer routine questions about FI 45.5 40/88 58.3 21/36 49.2 61/124
Relationship with doctor influences decision to consult 30.7 27/88 27.8 10/36 29.8 37/124
Doctors should be sensitive to medical costs 30.7 27/88 11.1 4/36 25.0 31/124
Doctors should overcome negative stigma 20.5 18/88 16.7 6/36 19.4 24/124
Discuss with physician if symptom is more severe N/A 55.6 20/36 17.7 22/124
Doctors should use every day terminology 15.9 14/88 11.1 4/36 14.5 18/124
Patients need more information: brochure 8.0 7/88 5.6 2/36 7.3 9/124
Patients will discuss only with a specialist 4.5 4/88 8.4 3/36 5.6 7/124
Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2016 April 23.
